Transcript CZ PRES Programme in HDG

Information needs for effective drug policy
in the programme of the CZ PRES
Identifying Europe’s information needs for effective drug
policy
Lisbon / 6-8 May 2009
As large knowledge, as large the pain
Old Testament; Book of Kohelet
The truth will make you free
St Augustin; Martin Heidegger; Sigmund Freud
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
CZ PRES PRIORITIES
Start of the implementation of EU AP


AP 2009-2012 approved by the EU Council - 8.12.2008
Implementation of activities with due time in 2009 already started
No. 5. - convene meetings of the national drugs coordinators - 29. April in
Prague
No. 19. - develop an EU consensus on minimum quality
standards and benchmarks for prevention, treatment,
harm reduction and rehabilitation
No. 20. - develop, as appropriate, services for minorities, including, for example, migrants
No. 56. - coordination between the HDG and MS delegations to the CND,
No.
57. - prepare and adopt EU common positions and
joint resolutions in the CND
No. 58. - present an EU position in the high-level segment of the 52nd CND
No. 67. - develop key-indicators for the collection of policyrelevant data on supply reduction
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
CZ PRES PRIORITIES
Present common EU position in the events organized by
OSN Commission on Narcotic Drugs
Activities:
No. 56. To ensure better coordination and continuity between the HDG and MS
delegations to the CND, including through the appropriate burden-sharing
among MS on the initiative of the Presidency
No. 57. To present an EU position in the high-level segment of the 52nd CND on
the evaluation of and follow-up to UNGASS '98, reflecting the fundamental
principles of EU drugs policy
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
Data collection and analysis – one of priorities of the EU
drug policy at the 52nd session of CND
To base policy measures on the best available evidence and information
- without high-quality data it is not possible to understand properly
what the situation is, and without that we have no chance to make
successful, appropriate, evidence-based decisions
 principles included into the Political Declaration and the Plan
of Action; however the Political Declaration is rather modest
when data collection and evaluation is concerned.
 resolution adopted on establishing the working group for
better data collection and analysis; however its efficiency is
in doubt
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
Specific - CZ PRES PRIORITIES
 Migration, Integration and Drugs
 Production, Trafficking and Use of Methamphetamine
 Efficient Coordination in Relations with Third Parties
Evaluation of Supply Reduction
Interventions

Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
The rationale behind developing supply reduction
indicators
The EU is committed to an evidence-based approach - focuses on
a continuous analysis of a problem and objective assessment of the
policy as a response to it.

 The EU / EMCDDA has succeeded in developing key indicators on
the demand side
 Supply reduction indicators is highly underdeveloped area
compared to demand reduction ones (= one of the weak points of
the evaluation of EU AP)
“(..) The (EU) Drug Strategy's objective of making it easier to measure supply
reduction and law enforcement output more effectively, is complicated by a lack of
availability of standardized key indicators in this area. (..)” (Final Evaluation of AP
2005-2008)
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
The rationale behind developing supply reduction
indicators
 Evaluation culture in supply reduction is much lower
than in demand reduction
 yet we spend most drug policy resources on supply
reduction
 As a consequence, aims and goals in supply reduction
are usually looser and mostly performance oriented, not
evaluating impacts
 it is also a long term interest of the (CZ) National Drug
Commission, NFP, Police, and in the management and
political representation of CZ Ministry of Interior
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
The rationale behind developing supply reduction
indicators
Objective 23. Further develop instruments to
monitor the drug situation and the effectiveness of
responses to it:
Action 67 – To develop key indicators for the
collection of policy-relevant data on drug-related
crime, illegal cultivation, drug markets and supply
reduction and to develop a strategy to collect them
Action 68 – To develop analytical instruments to
better assess the effectiveness and impact of drug
policy (e.g. model evaluation tools, policy
effectiveness indices, public expenditure analysis,
etc.)
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
Developing supply reduction indicators
 CZ established a working group with the aim to develop
supply reduction
indicators
 Outcomes of the working group presented at HDG
meeting in March
 CZ PRES prepared a „Council Conclusions“ discussed at
the HDG in April and agreed in May
 Outcomes of pilot data collection for defined supply
reduction indicators in
June.
CZ will be presented at HDG in
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
Conclusions

the cornerstone of the EU drugs policy is to base policy
on the best available evidence and information - in
order to make successful, appropriate, evidence-based
decisions

it is a necessity to have high-quality, comparable data
both on the demand as on the supply reduction side

EMCDDA has significantly contributed to the
implementation and development of monitoring and
policies at the national level in MS therefore,

in this process the EMCDDA plays consolidated role as a
leader for drug statistic and in developing data
collection systems both on the demand as well as on
the supply side
Identifying Europe’s information needs for effective drug policy
Lisbon / 6-8 May 2009
After conclusions

Does a drug policy, even based on the best available
evidence and information, have an impact on drug
situation?

Is there evidenced that evidence based approach is
effective?
Thank you for your attention.
Please be friends of the Czech Presidency!
Please be friends of EMCDDA!
Kamil Kalina
[email protected]